SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Medicine Products:(Date:5/16/2008)... Live Web Cast Scheduled for May 19 at 10:15 a.m....tCall/ - Response Biomedical,Corporation (TSX: RBM...,Chief Executive Officer, is scheduled to present ...re Conference on Monday May 19th at 10:15 a.m.,EDT...ailable on the Company,s,Web site at, http://www.r...
(Date:5/16/2008)...t this country needs is more unemployed politician...swire-FirstCall/ -- Although nearly all,voters pla... issues" list,a looming federal budgetary crunch ...y of the current presidential candidates is likely...te Majority Leader Bill Frist., Jousting with Pri...
(Date:5/16/2008)...ONDON, May 16 /PRNewswire/ -- Huntsworth plc (LSE:... relations and healthcare communications,group hea...ent report with,respect to the Group,s performance...h 31, 2008)., The statement follows below., 15... plc, Interim Management Sta...
(Date:5/16/2008)... Appeals for Funds Focus on Millions of Children S...The U.S. Fund for UNICEF and The,Advertising Counc... promote,a series of national public service annou...uding Ben Stiller, Nicole Ritchie, Joel Madden, Da...ed to help survivors of the,Myanmar cyclone. The A...
Breaking Medicine News(10 mins):Health News:Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3..., Feinberg School of Medicine have reported in Jou... inactivity and obesity // reduces the cardio-resp...sterol and blood pressure levels leading to increa...ers conducted their survey in U.S. population in t...
...reating psychological disorders. Carl Rogers intro...as been lot of questions about this technique. But... view problems of their patients from a different ...ory to various existing approaches present at that...
.... Zhou, 41 year old factor worker from the Sanming...he seventh victim of bird flu infection in China, ...er and pneumonia. It is not yet known how she got... contact with poultry and moreover she did not tak...
... by rabies which is transmitted through the saliva...ion // is required for a person who is bitten by .... If bite from an animal is unprovoked, it is safe...tested for the infection. If found infected, the a...
Other Medicine News:(Date:5/16/2008)...., May 16 /- Veridex, LLC announced t...orporation of America Holdings,(LabCorp), has comm...prostate cancer. The new assay uses the biological...er, detecting the methylation of the gene,GST-Pi. ...rimarily in,cancer. Veridex is developing the meth...
(Date:5/15/2008)... Confirm Efficacy for Population Most Affected by ...y 16 /-,Bayer HealthCare Ph...,(Nasdaq: ONXX ) today announced that Nexavar(R) ... survival by 47.3 percent (HR=0.68;,p-value=0.014)...ced,hepatocellular carcinoma (HCC), or primary liv...
(Date:5/15/2008)...O, May 15 /- Medivation, In... an ongoing Phase 1-2 clinical,trial of its novel ...sented,in an oral presentation at the 44th America...ng in Chicago., Session title: New Targeted Str... date and time: Monday, June 2 at 11:30 a.m. Centr...
(Date:5/15/2008)...Presented at ASCO Showed Acceptable Tolerability P...and 4 Neuropathy, WOODCLIFF LAKE, N.J., May 15 /P... agent eribulin mesylate (E7389) demonstrated acti...ith locally advanced or metastatic,breast cancer, ...inical,trial. The study also suggests that eribuli...
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Media highlights in the March 1 issue of Biophysical Journal 2310 1Sunrise Announces Release Date for Fourth Quarter Preliminary Selected Financial and Operating Data 12666 1Doing Angioplasty Long After Heart Attack Still Worth It Analysis Shows 12661 1Doing Angioplasty Long After Heart Attack Still Worth It Analysis Shows 12661 2Stereotaxis Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call 12656 1...Data Suggests Less Abuse-Related Effects For OROS(...ential Benefit of Unique OROS(r),Formulation , SAN...mains an,ongoing concern for parents and physician...icit Hyperactivity Disorder,(ADHD). Data presented...rican Psychiatric Association highlighted findings...
...lence of Alcohol Abuse Among ADHD Patients Nearly ...ximately 1 Million People, INDIANAPOLIS, May 23, 2...linical study showed Strattera(R) (atomoxetine HCl...ivity Disorder,(ADHD) in patients with comorbid al...ed safely and effectively with Strattera in,patien...
Other Medicine Technology:New Data Focuses on Abuse of Stimulant Medication 2New Data Focuses on Abuse of Stimulant Medication 3New Data Focuses on Abuse of Stimulant Medication 4New Data Focuses on Abuse of Stimulant Medication 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6